OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL. Nabid A, Carrier N, Vigneault E, Van Nguyen T, et al. Int J Radiat Oncol Biol Phys 2021 Apr 23. pii: S0360-3016(21)00373.

Read + Share

Amedeo Smart

Independent Medical Education

Nabid A, Carrier N, Vigneault E, Van Nguyen T, et al. OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL. Int J Radiat Oncol Biol Phys 2021 Apr 23. pii: S0360-3016(21)00373.
PMID: 33901566